Next Article in Journal
Clinical Impact of Rapid Bacterial Microbiological Identification with the MALDI-TOF MS
Next Article in Special Issue
Interhospital Spread of blaVIM-1- and blaCTX-M-15-Producing K. pneumoniae ST15 on an IncR Plasmid in Southern Spain
Previous Article in Journal
Brazilian Clinical Strains of Actinobacillus pleuropneumoniae and Pasteurella multocida: Capsular Diversity, Antimicrobial Susceptibility (In Vitro) and Proof of Concept for Prevention of Natural Colonization by Multi-Doses Protocol of Tildipirosin
Previous Article in Special Issue
Role of Relebactam in the Antibiotic Resistance Acquisition in Pseudomonas aeruginosa: In Vitro Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antibiotics
Volume 12
Issue 12
10.3390/antibiotics12121659
antibiotics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient

by
Alessandra Piccirilli
1,*,
Sascia Di Marcantonio
1,
Venera Costantino
2,
Omar Simonetti
3,
Marina Busetti
2,
Roberto Luzzati
3,
Luigi Principe
4,
Marco Di Domenico
5,
Antonio Rinaldi
5,
Cesare Cammà
5 and
Mariagrazia Perilli
1
1
Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, 67100 L’Aquila, Italy
2
Microbiology Unit, Trieste University Hospital (ASUGI), 34125 Trieste, Italy
3
Infectious Diseases Unit, Trieste University Hospital (ASUGI), 34125 Trieste, Italy
4
Clinical Pathology and Microbiology Unit, “S. Giovanni di Dio” Hospital, 88900 Crotone, Italy
5
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, Campo Boario, 64100 Teramo, Italy
*
Author to whom correspondence should be addressed.
Antibiotics 2023, 12(12), 1659; https://doi.org/10.3390/antibiotics12121659
Submission received: 12 October 2023 / Accepted: 23 November 2023 / Published: 25 November 2023
(This article belongs to the Special Issue Antibiotics Resistance and Molecular Epidemiology of Carbapenem-Resistance Bacteria)
Browse Figures
Review Reports Versions Notes

Abstract

:
In the present study, we analyzed the genome of two S. enterica strains TS1 and TS2 from stool and blood cultures, respectively, and one strain of C. freundii TS3, isolated from a single hospitalized patient with acute myeloid leukemia. The S. enterica Goldcoast ST358 (O:8 (C2-C3) serogroup), sequenced by the MiSeq Illumina system, showed the presence of β-lactamase genes (blaVIM-1, blaSHV-12 and blaOXA-10), aadA1, ant(2″)-Ia, aac(6′)-Iaa, aac(6′)-Ib3, aac(6′)-Ib-cr, qnrVC6, parC(T57S), and several incompatibility plasmids. A wide variety of insertion sequences (ISs) and transposon elements were identified. In C. freundii TS3, these were the blaVIM-1, blaCMY-150, and blaSHV-12, aadA1, aac(6′)-Ib3, aac(6′)-Ib-cr, mph(A), sul1, dfrA14, ARR-2, qnrVC6, and qnrB38. IncA plasmid isolated from E.coli/K12 transconjugant and C. freundii exhibited a sequence identity >99.9%. The transfer of IncA plasmid was evaluated by conjugation experiments.

1. Introduction

Salmonella enterica is an intracellular facultative anaerobe Gram-negative bacterium, belonging to the family of Enterobacterales. This common zoonotic pathogen is responsible for infections in both humans and animals [1]. Salmonella infection poses a major public health concern worldwide as a foodborne illness. Salmonellosis is the second most commonly reported gastrointestinal infection in the EU/EEA, and an important cause of food-borne outbreaks [2,3]. There are more than 2600 serovars of Salmonella on the basis of the lipopolysaccharide (LPS) O antigen and the flagellar protein (H) antigen [4]. From the clinical point of view, S. enterica subspecies enterica is the primary cause of human infections. S. enterica species can be subdivided into two big groups including the invasive typhoidal group (i.e., S. Typhy, S. Paratyphy A, B and C) and non-typhoidal Salmonella. Several hundred serovar of the S. enterica subspecies enterica are identified in different animal species (i.e., cattle, pig, poultry, human, etc.) [5,6]. Invasive typhoidal Salmonella causes enteric fever with clinical and severe complications if not treated [7]. Nontyphoidal Salmonella (NTS) strains include the S. enterica serovar Goldcoast, a rare zoonotic pathogen for human infection. The infection is usually acquired through contaminated food of animal origin [8]. S. enterica Goldcoast is a rare serovar for humans in the United States but it is more common in European countries. To date, a few epidemic outbreaks involving S. enterica Goldcoast have been described in Germany, Hungary, England, and Italy [9,10,11,12]. Recently, the increasing resistance to antimicrobials in Salmonella has posed a significant threat to public health. Salmonella strains resistant to ampicillin, trimethoprim-sulfamethoxazole, chloramphenicol, extended-spectrum cephalosporins, fluoroquinolones, tetracyclines and even carbapenems have emerged worldwide [1,13]. Β-Lactams are the most common antibiotics employed in clinical practice and their extensive use has led to the emergence of resistance. The World Health Organization (WHO) has estimated a high risk of the dissemination of antibiotic resistant bacteria (ARB) and an urgent worldwide action plan is required [14]. Carbapenems represent the “last-line agents” of defense for serious clinical infections caused by multidrug-resistant (MDR) Gram-negative bacteria and β-lactamases resistant to carbapenems (i.e., “carbapenemases”) are disseminated, mainly, among Enterobacterales. Currently, carbapenem-resistant Enterobacterales (CPEs) represent a serious problem in healthcare settings [14]. Resistance to carbapenems is due to the cooperation of different mechanisms including (i) production of carbapenemases, extended-spectrum-β-lactamases and AmpC, (ii) mutations that alter the expression and function of PBPs and porins, and (iii) efflux pump alteration [15]. The most worrisome carbapenemases found in Enterobacterales are represented by subclass B1 metallo-β-lactamases (MBLs) (i.e., NDM, VIM, and IMP), class A (i.e., KPC), and class D (i.e., OXA-48) enzymes of the Ambler classification. MBLs utilize one or two zinc ions for their catalysis while class A and D carbapenemases are serine-β-lactamases able to hydrolyze the β-lactams substrates by forming a transient or stable acyl enzyme through an active site serine. The dissemination of carbapenemase genes in bacterial isolates is due to their localization in mobile genetic elements which play a central role in facilitating horizontal genetic exchange and therefore promote the acquisition and spread of resistance genes. The most widespread CPEs worldwide in clinical settings are Klebsiella pneumoniae and Escherichia coli [16]. However, other CPEs causing nosocomial infections such as Citrobacter spp. and Salmonella spp. have, recently, been emerging [17,18]. Molecular epidemiology data on carbapenem-resistant Citrobacter spp. indicate the presence of class A and D carbapenemases (i.e., KPC-types and OXA-48, respectively) and MBLs (i.e., NDM-, VIM-, and IMP-variants) [17]. Even though carbapenems are not the drugs of choice for Salmonella infections, the presence of carbapenemases has been detected in NTS S. enterica identified in humans, animals, and food [19,20,21,22]. In particular, the first member of MBLs, the IMP-4 enzyme, was identified in a S. waycross isolate recovered in 2007 in Australia from an 87-year-old woman with a urinary tract infection followed by diarrhea [23]. However, the most common MBL reported worldwide in S. enterica is VIM-2, isolated for the first time in 2010 from the blood and urine of hospitalized patient in Morocco [24]. To date, the blaVIM-1 gene has mainly been identified in S. enterica strains isolated from livestock farms and food [25,26,27].
In the present study, we have reported a detailed characterization of a genome of two S. enterica (TS1 and TS2) strains and C. freundii TS3 isolated, from the stool and blood cultures of a single patient admitted to the University Hospital of Trieste (Northeastern Italy) with acute myeloid leukemia who underwent allogeneic stem cell transplantation complicated by graft-versus-host disease (GVHD). The IncA plasmid identified in both S. enterica and C. freundii was sequenced by Illumina and Nanopore systems in order to verify sequence similarity. Conjugation experiments were performed to support the theory of a possible “jump” in IncA plasmid or genetic determinants between S. enterica and C. freundii. Antibiotic resistance genes (ARGs), mobile genetic elements, and virulence factors were identified in both strains.

2. Results

2.1. Clinical Aspects and Strains Selection

We describe a patient with acute myeloid leukemia who underwent allogeneic stem cell transplantation (March 2022) complicated by graft-versus-host disease (GVHD). In late November 2022, the patient was hospitalized for acute diarrhea. Stool and blood cultures were positive for the third-generation cephalosporin-susceptible group C S. enterica. The strain was susceptible to carbapenems, cephalosporins, and aminoglycosides. In addition, Clostridioides difficile infection (CDI) was diagnosed. The patient was treated with fidaxomicin (10 days) and ceftriaxone (14 days) with clinical improvement and was discharged. Rectal colonization by KPC-producing K. pneumoniae and VIM-producing C. freundii was also detected. In late December 2022, the patient was readmitted for CDI recurrence that was treated with fidaxomicin (a tapered regimen for 20 days) and bezlotoxumab. The S. enterica group C was again identified from blood and stool cultures. Indeed, a second targeted antibiotic therapy with high-dose meropenem plus fosfomycin (14 days both) was administered. The Xpert Carba-R assay was carried out on S. enterica TS1, S. enterica TS2, and C. freundii TS3, and the presence of the blaVIM gene was detected in these strains. The patient experienced a gradual improvement with symptoms resolution but remained hospitalized for GVHD management. A PET scan ruled out a deep-seated infection and bloodstream clearance was documented. In late January 2023, hospital-acquired pneumonia (HAP) was diagnosed. High-dose meropenem and colistin were started. Due to clinical deterioration and the recurrence of bloodstream infection (BSI) due to VIM-producing group C S. enterica, the antibiotic regimen was modified in high-dose tigecycline, cefiderocol, and colistin. The samples underwent genomic sequencing. Recurrent BSI due to infected gallstones and secondary HAP were hypothesized. After targeted therapy and removal of all intravascular devices, the blood cultures collected were negative. Unfortunately, the patient died of causes unrelated to the infection ten days later.

2.2. Antimicrobial Susceptibility of S. enterica and C. freundii

The S. enterica TS1 and S. enterica TS2 isolated from stool and blood cultures, respectively, were analyzed for their susceptibility profile against different antibiotics. Both strains showed resistance to cephalosporins and ciprofloxacin, susceptibility at increased exposure to imipenem, and susceptibility to meropenem, aminoglycosides, and tigecycline (Table 1). The C. freundii strain showed resistance to cephalosporins, susceptibility at increased exposure to imipenem, susceptibility to meropenem, aminoglycosides, ciprofloxacin, and tigecycline.

2.3. Genomic Features of S. enterica TS1 and TS2

Molecular analysis, performed by next-generation sequencing, of S. enterica TS1 and S. enterica TS2 showed the same genetic features (MLST, serovar, plasmids, ARGs, virulence factors, etc); therefore, from this point on we refer only to S. enterica TS2 isolated from the blood culture. The whole-genome sequence (WGS) of S. enterica TS2 consisted of 111 contigs, which comprise 5,094,694 bases. The overall G+C content amounted to 51.97%. According to the MLST Achtman scheme, which considers seven housekeeping genes (aroC, dnaN, hemD, hisD, purE, sucA, and thrA) the strain belonged to ST358. The S. enterica TS2 serovar, predicted by SeqSero 1.2, showed the Goldcoast serotype (antigenic formula: 8: r: l, w). S. enterica Goldcoast is a serovar of the O:8 (C2-C3) serogroup. The resistome of S. enterica Goldcoast TS2 showed a copious number of ARGs (Table 2). Concerning β-lactamases, the presence of the blaVIM-1, blaSHV-12, and blaOXA-10 determinants was ascertained. Resistance to aminoglycosides was represented by the aadA1, ant(2″)-Ia, aac(6’)-Iaa, aac(6’)-Ib3, and aac(6’)-Ib-cr determinants. The presence of aac(6’)-Ib-cr indicated simultaneous resistance to aminoglycosides and quinolones. However, resistance to quinolones was also mediated by the qnrVC6 gene and it was chromosomally related to the mutation in parC(T57S). Other ARGs responsible for resistance to macrolides (mph(A)), rifampicin (ARR-2), sulphonamides (sul1), tetracyclines (tet(B)), chloramphenicol (catB8), trimethoprim (dfrA14), and antiseptics (qacE) were also detected. The WGS data of S. enterica TS2 indicated that the isolate had several incompatibility plasmids such as IncA, IncHI2, IncHI2A, and IncFII(29). The pMLST showed that IncA and IncHI2 were represented by the ST12 and ST1 lineages, respectively. A wide variety of insertion sequences (ISs) and transposon elements were identified in the analyzed strain (Table 2). In detail, transposons Tn6196 and Tn1000 (Tn gamma delta) were detected. Sequence insertion elements such as IS6100 of a length of 880 bp, ISEc52 of a length of 1250 bp, IS903 of a length of 1057 bp, ISAs22b of a length of 1198bp, ISSty2 of a length of 1259 bp, IS421 of a length of 1340 bp, and MITEEc1 belonging to the IS630 family were identified in the genome of S. enterica TS2.
Six Salmonella pathogenicity islands (SPIs) (SPI-1, SPI-2, SPI-3, SPI-4, SPI-5, and SPI-13) and centisome 63 (C63PI) were found in the S. enterica Goldcoast genome. Several virulence genes were correlated with SPIs elements, such as phoQ, sipA, sipB, sipC, and mgtB. In SPI-1, the clusters inv (invA, C, E, and G) and hilA, C, D were also identified (Table 3). In SPI-2, sseB, C, E, and D genes were detected. Among conserved Salmonella fimbrial gene clusters (FGCs), std, stb, stc, sth, bcf, and fim were ascertained. The strain harbored the cdtB and pltA genes, related to the typhoid toxin, typical of S. Typhi and S. Paratyphi. S. enterica ST358 analyzed in this study also harbored the pipB2, sseK2, and ssaI virulence genes involved in intracellular proliferation, survival, and biofilm formation.

2.4. Genomic Features of C. freundii TS3

The C. freundii TS3 strain showed a draft genome of 5.251.986 bp and 91 contigs, with a G+C content (%) of 51.91%. Multi-locus sequence typing of C. freundii showed the ST62 lineage (http://pubmlst.org/organisms/citrobacter-spp/, accessed on 25 January 2023). Resistome analysis revealed the presence of genes encoding for resistance to aminoglycosides (aadA1, aac(6′)-Ib3, aac(6′)-Ib-cr), macrolides (mph(A)), sulphonamides (sul1), trimethoprim (dfrA14), antiseptics (qacE), and rifampicin (ARR-2). Quinolone resistance was mediated by qnr elements (qnrVC6 and qnrB38), and the bi-functional aac(6′)-Ib-cr gene. The presence of blaVIM-1, blaCMY-150, and blaSHV-12 β-lactamases was also ascertained (Table 4). The C. freundii TS3 strain harbored an IncA plasmid pMLST ST12. As shown in Table 4, several ISs, such as IS6100 (880bp), IS5 (1195 bp), ISSen4 (1221 bp), and ISAs22 (1198 bp) were identified.

2.5. IncA Plasmid Mapping

In order to verify the sequence similarity of the IncA plasmid identified in S. enterica and C. freundii, the IncA plasmid was extracted from C. freundii TS3 and from transconjugant E. coli K12/S. enterica (see conjugation experiments in the materials and methods section). A total of 1.699.858.150 bp paired-end raw reads (510 Mb) were obtained by Illumina, and 126.920 raw reads with a mean length of 909.8 bp (115 Mb) by ONT for the C. freundii plasmid. The hybrid assembly produced 278 contigs with a largest contig of 150,373 bp. All contigs were used as inputs for MOB-suite to define their molecular type, only three were marked as plasmid sequences including the largest contig that results as a complete and circular plasmid. The IncA plasmids from transconjugant E. coli K12/S. enterica and C. freundii showed a sequence identity, by BLAST analysis, higher than 99.9%. The main genetic elements identified in the IncA plasmid were represented by plasmid replication module (repA), ARGs, IS family transposases, and genetic elements related to a conjugal transfer function. IncA harbored blaVIM-1 and blaSHV-12 which confer resistance to carbapenems and extended-spectrum β-lactams; aacA4 is an aminoglycoside N-acetyltransferase that confers resistance to broad-spectrum aminoglycosides; qnrVC6 confers resistance to fluoroquinolones; ant1 is a streptomycin adenyltransferase; and the mph(A) gene is a macrolide phosphotransferase, which, mainly, inactivates erythromycin. A similarity search in a public sequence database indicated the presence, in the IncA plasmid, of 12 conjugation genes (traB to traW). The traF, traG, and traH genetic elements, identified as components of outer membrane complex, seem to be involved in conjugation transfer (Figure 1).
The IncA plasmid harbored a class 1 integron which includes (i) an integrase 1 gene from 117,171 bp to 116,158 bp, (ii) a variable region of about 4000 bp including five gene cassettes (blaVIM-1, aacA4, qnrVC6, arr2, and ant1), and (iii) a 3′CS region including qacEdelta1 and sul1 genes (Figure 2). Upstream and downstream of integron element, there are typical elements of transposon.

2.6. IncA Transfer by Conjugation Assays

The transfer of IncA plasmid was evaluated by conjugation experiments. The selection of transconjugants was performed in plates supplemented with ceftazidime having ascertained the presence, in the IncA plasmid, of blaVIM-1 and blaSHV-12. Resistance to ceftazidime in E. coli K12 transconjugants was surely conferred by blaSHV-12. The correct transfer of the IncA plasmid was confirmed by amplification of the blaVIM-1 and blaSHV-12 genes in the E. coli K12 transconjugant of S. enterica and the E. coli K12 transconjugant of C. freundii.

3. Discussion

Herein we describe the first identification in Italy of the VIM-1-producing S. enterica serovar Goldcoast ST358 isolated from the blood and stool cultures of a single patient colonized by multiple germs including K. pneumoniae, C. difficile, and C. freundii during a hospitalization for acute myeloid leukemia. The genome DNA of S. enterica (TS1 and TS2 strains) and C. freundii was sequenced and various ARGs were identified in the chromosome and plasmids of these clinical isolates. IncA was identified in both the S. enterica TS2 and C. freundii TS3 strains. In addition to IncA, S. enterica also possessed IncHI and IncFII plasmids. The complete sequence of incompatibility of the IncA plasmid, carrying blaVIM-1, recovered by both S. enterica TS2 and C. freundii TS3, showed a nucleotide sequence similarity higher than 99%, suggesting a possible transfer of IncA between the two isolates. The theory that C. freundii TS3 exchanged IncA plasmid with S. enterica TS2 or vice versa, during the patient’s hospitalization, was supported by the positive results of “in vitro” conjugation experiments and the presence of a genetic complex system subordinated to the conjugal function [28]. The IncA/C plasmids have an extremely broad host range coupled with a high ability to spread via conjugative transfer [29,30,31]. Conjugation is the most effective mechanism for horizontal gene transfer (HGT). In this context, various incompatibility plasmids have a huge impact on the global emergence of MDR bacteria in clinical, animal, and environmental settings [32,33]. Recently, a highly conjugative IncA plasmid has been characterized in several VIM-1-producing Enterobacterales [34]. Arcari and coworkers identified, in VIM-IncA, several genetic regions (IS6000, dfrA14, mph(A), blaSHV-12, aac(6′)-Ib3, and aadA1) which were also encountered in our strains [34]. Despite the presence of blaVIM-1 in the IncA plasmid, both S. enterica TS2 and C. freundii TS3 were found to be susceptible to imipenem and meropenem. This is not unusual because several studies have reported low-carbapenem minimum inhibitory concentration values (MICs) in VIM-1-producing Enterobacterales [35,36]. In the chromosome of S. enterica, we have identified OXA-10, a class D oxacillinase commonly produced by Pseudomonas aeruginosa, which has been described as possessing weak activity against carbapenems [37]. The presence, in the IncA plasmid, of a class 1 integron with five gene cassettes has led to its rapid dissemination among bacteria, in particular when they are exposed to antibiotics. The IncA plasmid harbored the blaSHV-12 gene, whose presence also confers resistance to extended-spectrum β-lactams, and the fluoroquinolones and aminoglycoside resistance genes (qnrVC6 and aacA4, respectively). qnrVC6 is an emerging quinolone-resistance determinant in the qnr family which has mainly been identified in non-Enterobacterales species such as Acinetobacter baumannii, Pseudomonas spp., and C. freundii or, occasionally, in Vibrio parahaemolyticus [38,39,40,41]. In S. enterica TS2, resistance to fluoroquinolones is not only due to qnrVC6 but also to aac(6′)Ib-cr and mutation in T57S amino acid substitution in parC. Mutation in parC, identified in the QRDR of S. enterica reduces susceptibility to ciprofloxacin even if ciprofloxacin is a drug of choice for treating S. enterica infections in humans [42]. In S. enterica TS2, the situation is exacerbated by the presence of virulence factors, in particular those belonging to fimbrial adherence determinants which are involved in the attachment of Salmonella cells to the epithelium of gut. The majority of virulence genes are positioned within SPIs on chromosome or virulence plasmids. To date, 21 SPIs have been identified in Salmonella spp. [43].
The interesting point of the present study is the finding of blaVIM-1-producing S. enterica Goldcoast in a bloodstream infection. Indeed, the S. enterica serovar Goldcoast is an NTS-causing zoonotic foodborne disease and it was isolated for the first time in Ghana in 1953 [44]. Based on a European Food Safety Authority (EFSA) report in the 2020–2021 period, carbapenemase-producing Salmonella have not been detected in humans and food-producing animals [45]. After the first isolation of S. enterica Goldcoast, sporadic cases have been identified in Europe. Nevertheless, since 1984–1985, S. enterica Goldcoast started to be isolated in Europe more frequently. An outbreak of S. enterica Goldcoast, recorded in 2009–2010 in Italy, as well as in other European countries, was caused by widespread consumption of pork-containing products [12]. In 2013, S. enterica Goldcoast, associated with whelk consumption, caused gastroenteritis in a large number of people in England [11]. By 2019, S. enterica Goldcoast was also reported in China and Taiwan [46,47,48]. The main drugs of choice for S. enterica treatment are broad-spectrum cephalosporins and fluoroquinolones, while carbapenems are reserved for severe infections. Nevertheless, resistance to carbapenems represents a real public health problem. The main carbapenemases identified in Salmonella from humans and food-producing animals are KPC-2 (class A), OXA-48 (class D), and MBLs in particular NDM-1, NDM-5, VIM-2, and IMP-4 [18]. In 2014, Sotillo and coworkers reported the emergence of the VIM-1-producing S. enterica serovar Typhimurium in a pediatric patient [49]. Since then, the blaVIM-1 gene was found in the S. enterica serovar Infantis isolated in swine and poultry farms in Germany [26,50]. To date, the β-lactamases identified in S. enterica Goldcoast are TEM-1, CTX-M-55, OXA-48, AAC-1, and VIM-1 [25,46,51]. Based on an EFSA report (2021), 5.1% of S. enterica Goldcoast harbor the AmpC β-lactamases, in particular CMY-2 [2], which we did not detect in the strains analyzed in the present study. Analyzing the genome of C. freundii TS3, it has many ARGs in common with S. enterica Goldcoast TS2 (aadA1, aac(6′)-Ib3, aac(6′)-Ib-cr, sul1, dfrA14, and qacE). Unlike S. enterica TS2, C. freundii TS3 showed the presence of CMY-150, a CMY-2-variant, which confers resistance to ceftazidime and aztreonam [52]. Carbapenemase-producing Citrobacter spp. is particularly increasing in some geographical regions. The typical sequence types of Citrobacter spp., which have emerged as the dominant clones in healthcare settings, are ST19 and ST22 [53]. In Italy, the majority of VIM-1-producing C. freundii belong to ST22, ST112, ST523, and ST686 [17].

4. Materials and Methods

4.1. Strains Selection

Periodic screening rectal swabs were analyzed for the presence of MDR Gram-negative pathogens by selective chromogenic plates (Agar chromID CARBA SMART, bioMérieux, Marcy l’Étoile, France). Blood cultures were performed by BactAlert (bioMérieux, Marcy l’Étoile, France); positive bottles were subcultured on blood agar and selective chromogenic plates (Agar chromID CPS Elite, bioMérieux, Marcy l’Étoile, France). In diarrhoeic stools, the presence of Salmonella was detected on selective chromogenic plates (Agar chromID Salmonella Elite, BioMerieux). S. enterica typing was performed by serological tests (SeroQuick Id kit, SSI Diagnostica, Hillerød, Denmark). The presence of toxin-producing Clostridioides difficile was detected by molecular testing (Xpert C. difficile BT assay, Cepheid, Sunnyvale, CA, USA). The colonies were identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF) VitekMS (bioMérieux, Marcy l’Étoile, France). To detect carbapenem-resistant genes (blaVIM, blaIMP, blaNDM, blaKPC, and blaOXA-48), a molecular biology test was carried out by Xpert Carba-R assay (Cepheid, Sunnyvale, CA, USA).

4.2. Antimicrobial Susceptibility Testing

Antimicrobial susceptibility testing for Gram-negative organisms was carried out by broth microdilution test (Sensititre, ThermoFisher, Waltham, MA, USA) according to the manufacturer’s instructions. The following antimicrobial agents were tested: amikacin, cefotaxime, ceftazidime, cefepime, ciprofloxacin, gentamicin, imipenem, meropenem, and tigecycline. MICs were interpreted according to EUCAST 2022 criteria (https://www.eucast.org/clinical_breakpoints, accessed on 10 November 2022).

4.3. Genomic and Plasmid Extraction

Total nucleic acid was extracted from liquid cultures of S. enterica (TS1 and TS2 strains) and C. freundii TS3 using a modified protocol of the MagMAX Microbiome Ultra Nucleic Acid Isolation kit (Applied Biosystems, ThermoFisher Scientific, Monza, Italy) as previously reported [54]. The IncA plasmid was extracted from S. enterica TS2 and C. freundii TS3 using a Large-Construct Kit, which allows a purified plasmid free of genomic DNA contamination to be obtained.

4.4. Whole-Genome Sequencing (WGS) and Bioinformatic Analysis

Short-read sequencing libraries were prepared with an Illumina DNA Prep Kit (Illumina Inc. San Diego, CA, USA) and sequenced on an Illumina MiSeq instrument with a 2 × 300 bp paired-end protocol as previously described [55,56]. Quality control and sequence filtering were performed using DRAGEN FastQC + MultiQC v3.6.3 (https://basespace.illumina.com/apps/10562553/DRAGEN-FastQC-MultiQC, accessed on 21 January 2023). Paired-end reads were assembled with Velvet v1.2.10 (https://basespace.illumina.com/apps/8556549/Velvet-de-novo-Assembly, accessed on 21 January 2023).

4.5. WGS-Based AMR Identification and Serotype Prediction of S. enterica TS2

ResFinder 4.1 and PlasmidFinder 2.0 were used to detect acquired ARGs and plasmids, respectively (https://www.genomicepidemiology.org/services/, accessed on 25 January 2023). The genome was also assigned to ST using MLST 2.0 (https://cge.cbs.dtu.dk/services/MLST/, accessed on 25 January 2023). Identified plasmids of the IncF, IncH1, IncH2, IncI1, IncN, or IncA/C type were subtyped by pMLST 2.0 (https://cge.food.dtu.dk/services/pMLST/, accessed on 25 January 2023). Serotyping of Salmonella spp. was predicted by using WGS-assembled contig files (in FASTA format) with SeqSero1.2 (https://cge.cbs.dtu.dk/services/SeqSero/, accessed on 25 January 2023). Virulence factors and Salmonella Pathogenicity Islands were detected using the Virulence Factor Database (VFDB) (http://www.mgc.ac.cn/VFs/, accessed on 26 January 2023) and SPIFinder 2.0 (https://cge.food.dtu.dk/services/SPIFinder/, accessed on 25 January 2023), respectively. MobileElementFinder v.1.0.3 was used to identify mobile genetic elements (https://cge.food.dtu.dk/services/MobileElementFinder/, accessed on 25 January 2023).

4.6. WGS-Based AMR Identification of C. freundii TS3

ARGs, plasmids, mobile genetic elements, MLST and pMLST were detected as described in the above section, using services provided by Center for Genomic Epidemiology (https://www.genomicepidemiology.org/, accessed on 25 January 2023).

4.7. IncA Plasmid Sequencing

Plasmid DNA isolated from C. freundii was sequenced by both Illumina and Oxford Nanopore technologies (ONT) on NextSeq2000 setting 150 PE reads, and GridION using FLO-MIN112, respectively. Library preparation was accomplished using the DNA library prep (Illumina) and Native Barcoding Kit 24 SQK-NBD112.24 (ONT). Hybrid assembly was obtained using Unicycler v0.5.0 [57] combining short and long reads. Plasmid sequence was analyzed through the MOB-suite v.3.0.3 [58] which contains software tools for clustering, reconstruction, and typing of plasmids from draft assemblies. The plasmid was annotated by PROKKA v.1.14.5 [59] using the reference sequence FJ705807 [60]. Plasmid DNA isolated from S. enterica was sequenced by Oxford Nanopore technologies on GridION using the Native Barcoding Kit 24 SQK-NBD112.24 (ONT), and raw reads were assembled by Flye v.2.9.2 [61]. Finally, the sequence similarity of IncA plasmids was evaluated by blasting (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=MegaBlast&PROGRAM=blastn&PAGE_TYPE=BlastSearch&BLAST_SPEC=blast2seq, accessed on 25 March 2023) the draft plasmid sequence of S. enterica vs. the complete C. freundii plasmid.

4.8. Conjugation Experiments

S. enterica and C. freundii and E. coli K12 strains were used as donors and recipient for conjugation experiments, respectively. Transconjugants were selected on Luria-Bertani (LB) agar plates supplemented with 250 mg/L of streptomycin and 32 mg/L ceftazidime. The detection sensitivity of the assay was ≥5 × 10−7 transconjugants per recipient.

5. Conclusions

The increase in resistance to β-lactams is a result of the high plasticity of β-lactamases genes and the genetic adaptability of the bacterial population in a short period of time. The presence, in the IncA plasmid, of genetic components involved in conjugation (i.e., traF and traH) facilitates the genetic transfer of ARGs [28]. Carbapenem-resistant S. enterica Goldcoast and C. freundii are not considered to be a classical nosocomial pathogen but they possessed many genetic elements which conferred high resistance to several antibiotic families. Bloodstream S. enterica infections are very common and represent a real risk for public health, in particular when multiple bacterial species colonize the same patient [62]. The therapeutic options are very limited and the patient risks their own life.

Author Contributions

Conceptualization, M.P. and A.P.; methodology, S.D.M., V.C., M.D.D. and C.C.; investigation, O.S., A.P. and A.R.; data curation, A.P., M.B., O.S.; C.C. and A.R.; writing—original draft preparation, A.P., M.P., M.B. and O.S.; writing—review and editing, A.P., M.P., M.B., O.S., L.P., R.L. and C.C; supervision, A.P., M.P., M.B., O.S., L.P. and R.L.; funding acquisition, A.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the University of L’Aquila, Department of Biotechnological and Applied Clinical Sciences, grant number 07_DG_2023_15.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable. The study was conducted in the context of a normal clinical routine. All information about the patient has been anonymized. Samples were coded and analyzed with an anonymized database.

Data Availability Statement

Data are contained within the article.

Acknowledgments

The authors wish to thank Anna Toso (Toronto Catholic District School Board, Toronto, Canada) for the language revision of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Crump, J.A.; Sjölund-Karlsson, M.; Gordon, M.A.; Parry, C.M. Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance, and antimicrobial management of invasive Salmonella infections. Clin. Microbiol. Rev. 2015, 28, 901–937. [Google Scholar] [CrossRef] [PubMed]
  2. EFSA—European Food Safety Authority; ECDC—European Centre for Disease Prevention and Control. The European Union One Health 2020 Zoonoses Report. EFSA J. 2021, 19, 6971. [Google Scholar]
  3. European Centre for Disease Prevention and Control. Salmonellosis. In ECDC. Annual Epidemiological Report for 2021; ECDC: Stockholm, Sweden, 2022. [Google Scholar]
  4. Li, P.; Liu, Q.; Luo, H.; Liang, K.; Yi, J.; Luo, Y.; Hu, Y.; Han, Y.; Kong, Q. O-Serotype conversion in Salmonella typhimurium induces protective immune responses against invasive Non-Typhoidal Salmonella infections. Front. Immunol. 2017, 8, 1647. [Google Scholar] [CrossRef] [PubMed]
  5. Carey, M.E.; Dyson, Z.A.; Ingle, D.J.; Amir, A.; Aworh, M.K.; Chattaway, M.A.; Chew, K.L.; Crump, J.A.; Feasey, N.A.; Howden, B.P.; et al. Global Typhoid Genomics Consortium Group Authorship. Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes. Elife 2023, 12, e85867. [Google Scholar] [CrossRef]
  6. Chattaway, M.A.; Painset, A.; Godbole, G.; Gharbia, S.; Jenkins, C. Evaluation of genomic typing methods in the Salmonella reference laboratory in Public Health, England, 2012–2020. Pathogens 2023, 12, 223. [Google Scholar] [CrossRef] [PubMed]
  7. Marchello, C.S.; Birkhold, M.; Crump, J.A. Vacc-iNTS consortium collaborators. Complications and mortality of non-typhoidal Salmonella invasive disease: A global systematic review and meta-analysis. Lancet Infect. Dis. 2022, 22, 692–705. [Google Scholar] [CrossRef] [PubMed]
  8. Foley, S.L.; Lynne, A.M. Food animal-associated Salmonella challenges: Pathogenicity and antimicrobial resistance. J. Anim. Sci. 2008, 86, E173–E187. [Google Scholar] [CrossRef]
  9. Bremer, V.; Leitmeyer, K.; Jensen, E.; Metzel, U.; Meczulat, H.; Weise, E.; Werber, D.; Tschaepe, H.; Kreienbrock, L.; Glaser, S.; et al. Outbreak of Salmonella Goldcoast infections linked to consumption of fermented sausage, Germany 2001. Epidemiol. Infect. 2004, 132, 881–887. [Google Scholar] [CrossRef]
  10. Horváth, J.K.; Mengel, M.; Krisztalovics, K.; Nogrady, N.; Pászti, J.; Lenglet, A.; Takkinen, J. Investigation into an unusual increase of human cases of Salmonella Goldcoast infection in Hungary in 2009. Eurosurveillance 2013, 18, 204228. [Google Scholar] [CrossRef]
  11. Inns, T.; Beasley, G.; Lane, C.; Hopps, V.; Peters, T.; Pathak, K.; Perez-Moreno, R.; Adak, G.; Shankar, A. Outbreak of Salmonella enterica Goldcoast infection associated with whelk consumption, England, June to October 2013. Eurosurveillance 2013, 18, 20654. [Google Scholar] [CrossRef]
  12. Scavia, G.; Ciaravino, G.; Luzzi, I.; Lenglet, A.; Ricci, A.; Barco, L.; Pavan, A.; Zafanella, F.; Dionisi, A.M. A multistate epidemic outbreak of Salmonella Goldcoast infection in humans, June 2009 to March 2010: The investigation in Italy. Eurosurveillance 2013, 18, 20424. [Google Scholar] [CrossRef] [PubMed]
  13. EFSA—European Food Safety Authority; ECDC—European Centre for Disease Prevention and Control. The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2018/2019. EFSA J. 2021, 19, 6490. [Google Scholar]
  14. Murray, C.J.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Aguilar, G.R.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Antimicrobial Resistance Collaborators Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef] [PubMed]
  15. Bonomo, R.A.; Burd, E.M.; Conly, J.; Limbago, B.M.; Poirel, L.; Segre, J.A.; Westblade, L.F. Carbapenemase-Producing Organisms: A Global Scourge. Clin. Infect. Dis. 2018, 66, 1290–1297. [Google Scholar] [CrossRef]
  16. Bush, K.; Bradford, P.A. Epidemiology of β-lactamase-producing pathogens. Clin. Microbiol. Rev. 2020, 33, e00047-19. [Google Scholar] [CrossRef]
  17. Nobrega, D.; Peirano, G.; Matsumura, Y.; Pitout, J.D.D. Molecular epidemiology of global carbapenemase-producing Citrobacter spp. (2015–2017). Microbiol. Spectr. 2023, 11, e0414422. [Google Scholar] [CrossRef] [PubMed]
  18. Fernández, J.; Guerra, B.; Rodicio, M.R. Resistance to carbapenems in Non-Typhoidal Salmonella enterica serovars from humans, animals and food. Vet. Sci. 2018, 5, 40. [Google Scholar] [CrossRef]
  19. Miriagou, V.; Tzouvelekis, L.S.; Rossiter, S.; Tzelepi, E.; Angulo, F.J.; Whichard, J.M. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob. Agents Chemother. 2003, 47, 1297–1300. [Google Scholar] [CrossRef]
  20. Savard, P.; Gopinath, R.; Zhu, W.; Kitchel, B.; Rasheed, J.K.; Tekle, T.; Roberts, A.; Ross, T.; Razeq, J.; Landrum, B.M.; et al. First NDM-positive Salmonella spp. strain identified in the United States. Antimicrob. Agents Chemother. 2011, 55, 5957–5958. [Google Scholar] [CrossRef]
  21. Li, X.; Jiang, Y.; Wu, K.; Zhou, Y.; Liu, R.; Cao, Y.; Wu, A.; Qiu, Y. Whole-genome sequencing identification of a multidrug-resistant Salmonella enterica serovar Typhimurium strain carrying blaNDM-5 from Guangdong, China. Infect. Genet. Evol. 2017, 55, 195–198. [Google Scholar] [CrossRef]
  22. Seiffert, S.N.; Perreten, V.; Johannes, S.; Droz, S.; Bodmer, T.; Endimiani, A. OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland. Antimicrob. Agents Chemother. 2014, 58, 2446–2449. [Google Scholar] [CrossRef] [PubMed]
  23. Nordmann, P.; Poirel, L.; Mak, J.K.; White, P.A.; McIver, C.J.; Taylor, P. Multidrug-resistant Salmonella strains expressing emerging antibiotic resistance determinants. Clin. Infect. Dis. 2008, 46, 324–325. [Google Scholar] [CrossRef] [PubMed]
  24. Le Hello, S.; Harrois, D.; Bouchrif, B.; Sontag, L.; Elhani, D.; Guibert, V.; Zerouali, K.; Weill, F.X. Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: A microbiological study. Lancet Infect. Dis. 2013, 13, 672–679. [Google Scholar] [CrossRef] [PubMed]
  25. Roschanski, N.; Hadziabdic, S.; Borowiak, M.; Malorny, B.; Tenhagen, B.A.; Projahn, M.; Kaesbohrer, A.; Guenther, S.; Szabo, I.; Roesler, U.; et al. Detection of VIM-1-Producing Enterobacter cloacae and Salmonella enterica Serovars Infantis and Goldcoast at a breeding pig farm in Germany in 2017 and their molecular relationship to former VIM-1-Producing S. Infantis Isolates in German livestock production. mSphere 2019, 4, e00089-19. [Google Scholar]
  26. Fischer, J.; Rodríguez, I.; Schmoger, S.; Friese, A.; Roesler, U.; Helmuth, R.; Guerra, B. Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. J. Antimicrob. Chemother. 2013, 68, 478–480. [Google Scholar] [CrossRef] [PubMed]
  27. Falgenhauer, L.; Ghosh, H.; Guerra, B.; Yao, Y.; Fritzenwanker, M.; Fischer, J.; Helmuth, R.; Imirzalioglu, C.; Chakraborty, T. Comparative genome analysis of IncHI2 VIM-1 carbapenemase-encoding plasmids of Escherichia coli and Salmonella enterica isolated from a livestock farm in Germany. Vet. Microbiol. 2017, 200, 114–117. [Google Scholar] [CrossRef] [PubMed]
  28. Arutyunov, D.; Arenson, B.; Manchak, J.; Frost, L.S. F plasmid TraF and TraH are components of an outer membrane complex involved in conjugation. J. Bacteriol. 2010, 192, 1730–1734. [Google Scholar] [CrossRef]
  29. Poole, T.L.; Edrington, T.S.; Brichta-Harhay, D.M.; Carattoli, A.; Anderson, R.C.; Nisbet, D.J. Conjugative transferability of the A/C plasmids from Salmonella enterica isolates that possess or lack bla(CMY) in the A/C plasmid backbone. Foodborne Pathog. Dis. 2009, 6, 1185–1194. [Google Scholar] [CrossRef]
  30. Arpin, C.; Thabet, L.; Yassine, H.; Messadi, A.; Boukadida, J.; Dubois, V.; Coulange-Mayonnove, L.; Andre, C.; Quentin, C. Evolution of an Incompatibility Group IncA/C Plasmid Harboring blaCMY-16 and qnrA6 Genes and its transfer through three clones of Providencia stuartii during a 2-year Outbreak in a Tunisian Burn Unit. Antimicrob. Agents Chemother. 2012, 56, 1342–1349. [Google Scholar] [CrossRef]
  31. Carattoli, A.; Villa, L.; Poirel, L.; Bonnin, R.A.; Nordmann, P. Evolution of IncA/C blaCMY-2 carrying plasmids by acquisition of the blaNDM-1 carbapenemase gene. Antimicrob. Agents Chemother. 2012, 56, 783–786. [Google Scholar] [CrossRef]
  32. Poulin-Laprade, D.; Carraro, N.; Burrus, V. The extended regulatory networks of SXT/R391 integrative and conjugative elements and IncA/C conjugative plasmids. Front. Microbiol. 2015, 6, 837. [Google Scholar] [CrossRef]
  33. Johnson, T.J.; Lang, K.S. IncA/C plasmids: An emerging threat to human and animal health? Mob. Genet. Elements 2012, 2, 55–58. [Google Scholar] [CrossRef] [PubMed]
  34. Arcari, G.; Di Lella, F.M.; Bibbolino, G.; Mengoni, F.; Beccaccioli, M.; Antonelli, G.; Faino, L.; Carattoli, A. A Multispecies Cluster of VIM-1 carbapenemase-producing Enterobacterales linked by a novel, highly conjugative, and broad-host-range IncA plasmid forebodes the reemergence of VIM-1. Antimicrob. Agents Chemother. 2020, 64, e02435-19. [Google Scholar] [CrossRef] [PubMed]
  35. Falcone, M.; Perilli, M.; Mezzatesta, M.L.; Mancini, C.; Amicosante, G.; Stefani, S.; Venditti, M. Prolonged bacteraemia caused by VIM-1 metallo-β-lactamase-producing Proteus mirabilis: First report from Italy. Clin. Microbiol. Infect. Dis. 2010, 16, 179–181. [Google Scholar] [CrossRef] [PubMed]
  36. Falcone, M.; Mezzatesta, M.L.; Perilli, M.; Forcella, C.; Giordano, A.; Cafiso, V.; Amicosante, G.; Stefani, S.; Venditti, M. Infections with VIM-1 metallo-β-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J. Clin. Microbiol. 2009, 47, 3514–3519. [Google Scholar] [CrossRef]
  37. Kotsakis, S.D.; Flach, C.F.; Razavi, M.; Larsson, D.G.J. Characterization of the first OXA-10 natural variant with increased carbapenemase activity. Antimicrob. Agents Chemother. 2018, 63, e01817-18. [Google Scholar] [CrossRef] [PubMed]
  38. Tian, C.; Song, J.; Ren, L.; Huang, D.; Wang, S.; Fu, L.; Zhao, Y.; Bai, Y.; Fan, X.; Ma, T.; et al. Complete genetic characterization of carbapenem-resistant Acinetobacter johnsonii, co-producing NDM-1, OXA-58, and PER-1 in a patient source. Front. Cell Infect. Microbiol. 2023, 13, 1227063. [Google Scholar] [CrossRef]
  39. Liu, J.; Yang, L.; Li, L.; Li, B.; Chen, D.; Xu, Z. Comparative genomic analyses of two novel qnrVC6 carrying multidrug-resistant Pseudomonas spp. strains. Microb. Pathog. 2018, 123, 269–274. [Google Scholar] [CrossRef]
  40. Bado, I.; Papa-Ezdra, R.; Cordeiro, N.; Outeda, M.; Caiata, L.; García-Fulgueiras, V.; Seija, V.; Vignoli, R. Detection of qnrVC6, within a new genetic context, in an NDM-1-producing Citrobacter freundii clinical isolate from Uruguay. J. Glob. Antimicrob. Resist. 2018, 14, 95–98. [Google Scholar] [CrossRef]
  41. Zhang, Y.; Zheng, Z.; Chan, E.W.; Dong, N.; Xia, X.; Chen, S. Molecular Characterization of qnrVC Genes and Their Novel Alleles in Vibrio spp. Isolated from Food Products in China. Antimicrob. Agents Chemother. 2018, 62, e00529-18. [Google Scholar] [CrossRef]
  42. Souza, R.B.; Ferrari, R.G.; Magnani, M.; Kottwitz, L.B.; Alcocer, I.; Tognim, M.C.; Oliveira, T.C. Ciprofloxacin susceptibility reduction of Salmonella strains isolated from outbreaks. Braz. J. Microbiol. 2010, 41, 497–500. [Google Scholar] [CrossRef] [PubMed]
  43. Gao, R.; Wang, L.; Ogunremi, D. Virulence determinants of non-typhoidal Salmonellae. In Microorganisms; Intechopen: London, UK, 2019. [Google Scholar]
  44. Threlfall, E.J.; Hall, M.L.; Rowe, B. Salmonella Goldcoast from outbreaks of food-poisoning in the British Isles can be differentiated by plasmid profiles. J. Hyg. 1986, 97, 115–122. [Google Scholar] [CrossRef] [PubMed]
  45. European Food Safety Authority and European Centre for Disease Prevention and Control. The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from animals and food in 2020/2021. EFSA J. 2023, 21, 7867. [Google Scholar]
  46. Chang, Y.J.; Chen, C.L.; Yang, H.P.; Chiu, C.H. Prevalence, serotypes, and antimicrobial resistance patterns of non-typhoid Salmonella in Food in Northern Taiwan. Pathogens 2022, 11, 705. [Google Scholar] [CrossRef] [PubMed]
  47. Chen, C.M.; Tang, H.L.; Ke, S.C.; Lin, Y.P.; Lu, M.C.; Lai, Y.C.; Chen, B.H.; Wang, Y.W.; Teng, R.H.; Chiou, C.S. A nosocomial salmonellosis outbreak caused by blaOXA-48-carrying, extensively drug-resistant Salmonella enterica serovar Goldcoast in a hospital respiratory care ward in Taiwan. J. Glob. Antimicrob. Resist. 2022, 29, 331–338. [Google Scholar] [CrossRef] [PubMed]
  48. Wu, B.; Ed-Dra, A.; Pan, H.; Dong, C.; Jia, C.; Yue, M. Genomic investigation of Salmonella isolates recovered from a pig slaughtering process in Hangzhou, China. Front. Microbiol. 2021, 12, 704636. [Google Scholar] [CrossRef] [PubMed]
  49. Sotillo, A.; Muñoz-Vélez, M.; Santamaría, M.L.; Ruiz-Carrascoso, G.; García-Bujalance, S.; Gómez-Gil, R.; Mingorance, J. Emergence of VIM-1-producing Salmonella enterica serovar Typhimurium in a paediatric patient. J. Med. Microbiol. 2015, 64, 1541–1543. [Google Scholar] [CrossRef] [PubMed]
  50. Fischer, J.; San José, M.; Roschanski, N.; Schmoger, S.; Baumann, B.; Irrgang, A.; Friese, A.; Roesler, U.; Helmuth, R.; Guerra, B. Spread and persistence of VIM-1 carbapenemase-producing Enterobacteriaceae in three German swine farms in 2011 and 2012. Vet. Microbiol 2017, 200, 118–123. [Google Scholar] [CrossRef]
  51. Liao, Y.S.; Chen, B.H.; Hong, Y.P.; Teng, R.H.; Wang, Y.W.; Liang, S.Y.; Liu, Y.Y.; Tu, Y.H.; Chen, Y.S.; Chang, J.H.; et al. Emergence of multidrug-resistant Salmonella enterica serovar Goldcoast strains in Taiwan and international spread of the ST358 clone. Antimicrob. Agents Chemother. 2019, 63, e01122-19. [Google Scholar] [CrossRef]
  52. Dabos, L.; Rodriguez, C.H.; Nastro, M.; Dortet, L.; Bonnin, R.A.; Famiglietti, A.; Iorga, B.I.; Vay, C.; Naas, T. LMB-1 producing Citrobacter freundii from Argentina, a novel player in the field of MBLs. Int. J. Antimicrob. Agents 2020, 55, 105857. [Google Scholar] [CrossRef]
  53. Yao, Y.; Falgenhauer, L.; Falgenhauer, J.; Hauri, A.M.; Heinmüller, P.; Domann, E.; Chakraborty, T.; Imirzalioglu, C. Carbapenem-Resistant Citrobacter spp. as an emerging concern in the hospital-setting: Results from a genome-based regional surveillance study. Front. Cell Infect. Microbiol. 2021, 11, 744431. [Google Scholar] [CrossRef] [PubMed]
  54. Piccirilli, A.; Cherubini, S.; Brisdelli, F.; Fazii, P.; Stanziale, A.; Di Valerio, S.; Chiavaroli, V.; Principe, L.; Perilli, M. Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU). Diagnostics 2022, 12, 2180. [Google Scholar] [CrossRef] [PubMed]
  55. Cherubini, S.; Perilli, M.; Segatore, B.; Fazii, P.; Parruti, G.; Frattari, A.; Amicosante, G.; Piccirilli, A. Whole-Genome Sequencing of ST2 A. baumannii causing bloodstream infections in COVID-19 Patients. Antibiotics 2022, 11, 955. [Google Scholar] [CrossRef] [PubMed]
  56. Cherubini, S.; Perilli, M.; Azzini, A.M.; Tacconelli, E.; Maccacaro, L.; Bazaj, A.; Naso, L.; Amicosante, G.; Ltcf-Veneto Working Group; Lo Cascio, G.; et al. Resistome and virulome of multi-drug resistant E. coli ST131 isolated from residents of Long-Term Care Facilities in the Northern Italian Region. Diagnostics 2022, 12, 213. [Google Scholar] [CrossRef] [PubMed]
  57. Wick, R.R.; Judd, L.M.; Gorrie, C.L.; Holt, K.E. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 2017, 13, e1005595. [Google Scholar] [CrossRef] [PubMed]
  58. Robertson, J.; Nash, J.H.E. MOB-suite: Software tools for clustering, reconstruction and typing of plasmids from draft assemblies. Microb. Genom. 2018, 4, e000206. [Google Scholar] [CrossRef] [PubMed]
  59. Seemann, T. Prokka: Rapid prokaryotic genome annotation. Bioinformatics 2014, 30, 2068–2069. [Google Scholar] [CrossRef]
  60. Bitar, I.; Caltagirone, M.; Villa, L.; Mattioni Marchetti, V.; Nucleo, E.; Sarti, M.; Migliavacca, R.; Carattoli, A. Interplay among IncA and blaKPC-carrying plasmids in Citrobacter freundii. Antimicrob. Agents Chemother. 2019, 63, e02609-18. [Google Scholar] [CrossRef]
  61. Kolmogorov, M.; Yuan, J.; Lin, Y.; Pevzner, P.A. Assembly of long, error-prone reads using repeat graphs. Nat. Biotechnol. 2019, 37, 540–546. [Google Scholar] [CrossRef]
  62. Piccirilli, A.; Perilli, M.; Piccirilli, V.; Segatore, B.; Amicosante, G.; Maccacaro, L.; Bazaj, A.; Naso, L.; Cascio, G.L.; Cornaglia, G. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary university hospital of Verona (northern Italy): Co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases. Diagn. Microbiol. Infect. Dis. 2020, 96, 114968. [Google Scholar]
Antibiotics 12 01659 g001
Figure 1. Circular map of IncA plasmid. The circles, from the outermost to the innermost, show: (i) coding DNA sequences (CDSs) encoded on the plus and minus DNA strands (annotation is reported for known genes only); and (ii) the G+C content, shown as deviation from the average G+C content of the entire molecule. Genes encoding protein of known functions are in different colors, as detailed in the legend.
Figure 1. Circular map of IncA plasmid. The circles, from the outermost to the innermost, show: (i) coding DNA sequences (CDSs) encoded on the plus and minus DNA strands (annotation is reported for known genes only); and (ii) the G+C content, shown as deviation from the average G+C content of the entire molecule. Genes encoding protein of known functions are in different colors, as detailed in the legend.
Antibiotics 12 01659 g001
Antibiotics 12 01659 g002
Figure 2. Structure of the class 1 integron carried on the analyzed plasmid. The intI1 integrase gene is indicated by a violet arrow; the variable region includes five gene cassettes (red arrows).
Figure 2. Structure of the class 1 integron carried on the analyzed plasmid. The intI1 integrase gene is indicated by a violet arrow; the variable region includes five gene cassettes (red arrows).
Antibiotics 12 01659 g002
Table 1. Antimicrobial susceptibility pattern of S. enterica and C. freundii clinical strains.
Table 1. Antimicrobial susceptibility pattern of S. enterica and C. freundii clinical strains.
AntibioticsMIC (mg/L)
S. enterica
TS1, TS2 		C. freundii
TS3
Cefotaxime>4(R)>4(R)
Ceftazidime>128(R)>128(R)
Cefepime>16(R)>16(R)
Imipenem4(I)4(I)
Meropenem2(S)1(S)
Ciprofloxacin0.5(R)0.12(S)
Amikacin≤4(S)≤4(S)
Gentamicin2(S)2(S)
Tigecycline0.25(S)0.25(S)
Table 2. ARGs and mobile genetic elements in the S. enterica Goldcoast TS2 strain.
Table 2. ARGs and mobile genetic elements in the S. enterica Goldcoast TS2 strain.
Genotyping of S. enterica Goldcoast TS2 Strain
MLST Β-Lactam ResistanceAminoglycoside ResistanceMacrolide ResistanceQuinolone ResistanceRifampicin
Resistance		Others
ST358blaVIM-1
blaOXA-10
blaSHV-12		aadA1
ant(2″)-Ia
aac(6′)-Iaa
aac(6′)-Ib3
aac(6′)-Ib-cr		mph(A)qnrVC6
parC T57S
aac(6′)-Ib-cr		ARR-2sul1
tet(B)
catB8
dfrA14
qacE
Mobile genetic elements
TransposonsPlasmidspMLSTInsertion Sequences (ISs)
Tn1000
Tn6196		IncA,
IncHI2,
IncHI2A, IncFII(29)		IncA:(ST = 12)
IncHI2:(ST = 1)		IS6100 (IS6 family)
ISEc52
IS903
ISAs22b (IS3 family; IS407 group)
MITEEc1 (IS630 family)
ISSty2 (IS3 family)
IS421 (IS4 family; IS231 group)
Table 3. Virulence factors (VFs) in the S. enterica Goldcoast TS2 strain.
Table 3. Virulence factors (VFs) in the S. enterica Goldcoast TS2 strain.
VF ClassVirulence FactorsRelated Genes
Fimbrial Adherence DeterminantsAgf/CsgcsgG
BcfbcfB,C,D
FimfimC,D,H,Z
SafsafB,C
StbstbB,C,D
StcstcC,D
StdstdB,C
StesteB,C
StfstfC,D
SthsthC,E
StistiC,H
Macrophage Inducible GenesMig-14mig-14
Magnesium UptakeMg2+ transportmgtB
Nonfimbrial Adherence DeterminantsMisLmisL
RatBratB
SinHsinH
RegulationPhoPQphoQ
Secretion SystemTTSS (SPI-1 encode)hilA,C,D; invA,C,E,G; prgH; sipD; spaO,R,S;
TTSS (SPI-2 encode)ssaC,D,L,N,Q,U,V; sseC; ssrA
TTSS effectors translocated via both systemsslrP
TTSS-1 translocated effectorsavrA; sipA,B,C; sopA,B,D; sptB
TTSS-2 translocated effectorspipB2; pipB; sifA,B; sopD2; sseF,G,J,K1,K2,L
ToxinTyphoid toxincdtB, pltA
Table 4. ARGs and mobile genetic elements of the C. freundii TS3 strain.
Table 4. ARGs and mobile genetic elements of the C. freundii TS3 strain.
Genotyping of C. freundii TS3
MLST Β-Lactam ResistanceAminoglycoside ResistanceMacrolide ResistanceQuinolone ResistanceRifampicin ResistanceOthers
ST62blaVIM-1
blaCMY-150
blaSHV-12		aadA1
aac(6′)-Ib3
aac(6′)-Ib-cr		mph(A)qnrVC6
qnrB38
aac(6′)-Ib-cr		ARR-2sul1
dfrA14
qacE
Mobile genetic elements
PlasmidspMLSTInsertion Sequences (ISs)
IncAIncA:(ST = 12)IS6100 (IS6 family), IS5 (IS5 family), ISSen4 (IS3 family), ISAs22 (IS3 family)
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Piccirilli, A.; Di Marcantonio, S.; Costantino, V.; Simonetti, O.; Busetti, M.; Luzzati, R.; Principe, L.; Di Domenico, M.; Rinaldi, A.; Cammà, C.; et al. Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient. Antibiotics 2023, 12, 1659. https://doi.org/10.3390/antibiotics12121659

AMA Style

Piccirilli A, Di Marcantonio S, Costantino V, Simonetti O, Busetti M, Luzzati R, Principe L, Di Domenico M, Rinaldi A, Cammà C, et al. Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient. Antibiotics. 2023; 12(12):1659. https://doi.org/10.3390/antibiotics12121659

Chicago/Turabian Style

Piccirilli, Alessandra, Sascia Di Marcantonio, Venera Costantino, Omar Simonetti, Marina Busetti, Roberto Luzzati, Luigi Principe, Marco Di Domenico, Antonio Rinaldi, Cesare Cammà, and et al. 2023. "Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient" Antibiotics 12, no. 12: 1659. https://doi.org/10.3390/antibiotics12121659

APA Style

Piccirilli, A., Di Marcantonio, S., Costantino, V., Simonetti, O., Busetti, M., Luzzati, R., Principe, L., Di Domenico, M., Rinaldi, A., Cammà, C., & Perilli, M. (2023). Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient. Antibiotics, 12(12), 1659. https://doi.org/10.3390/antibiotics12121659

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop